EGFR and hepatocellular carcinoma: The lncRNA lnc-EGFR stimulates T-regulatory cell differentiation, thereby promoting HCC immune evasion (Jiang et al., 2017), while lncRNA-6195 inhibits α-enolase activity and thus HCC progression (Yu et al., 2018).